Updated Research Criteria for Clinical Trials Across the Alzheimer’s Disease Continuum


This article describes the implications of the 2017 National Institute of Aging and Alzheimer’s Association (NIA-AA) common research framework proposed to help investigators establish a research agenda and evaluate the impact of various therapeutics in the Alzheimer’s disease (AD) continuum, and specifically to define and stage AD and facilitate research reporting.